Article

Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin.

Neurobiology Program, University of Washington, Seattle, Washington 98195-7280, USA.
Journal of Biological Chemistry (impact factor: 4.77). 09/1999; 274(34):23802-7. pp.23802-7
Source: PubMed

ABSTRACT We used the Xenopus oocyte expression system to examine the regulation of rat kappa opioid receptor (rKOR) function by G protein receptor kinases (GRKs). kappa agonists increased the conductance of G protein-activated inwardly rectifying potassium channels in oocytes co-expressing KOR with Kir3.1 and Kir3.4. In the absence of added GRK and beta-arrestin 2, desensitization of the kappa agonist-induced potassium current was modest. Co-expression of either GRK3 or GRK5 along with beta-arrestin 2 significantly increased the rate of desensitization, whereas addition of either beta-arrestin 2, GRK3, or GRK5 alone had no effect on the KOR desensitization rate. The desensitization was homologous as co-expressed delta opioid receptor-evoked responses were not affected by KOR desensitization. The rate of GRK3/beta-arrestin 2-dependent desensitization was reduced by truncation of the C-terminal 26 amino acids, KOR(Q355Delta). In contrast, substitution of Ala for Ser within the third intracellular loop [KOR(S255A,S260A, S262A)] did not reduce the desensitization rate. Within the C-terminal region, KOR(S369A) substitution significantly attenuated desensitization, whereas the KOR(T363A) and KOR(S356A,T357A) point mutations did not. These results suggest that co-expression of GRK3 or GRK5 and beta-arrestin 2 produced homologous, agonist-induced desensitization of the kappa opioid receptor by a mechanism requiring the phosphorylation of the serine 369 of rKOR.

0 0
 · 
0 Bookmarks
 · 
19 Views
  • Source
    Article: Dual coupling of MT1 and MT2 melatonin receptors to cyclic AMP and phosphoinositide signal transduction cascades and their regulation following melatonin exposure
    [show abstract] [hide abstract]
    ABSTRACT: In this investigation, we wanted to determine whether MT1 or MT2 melatonin receptors are capable of coupling to the phosphoinositide (PI) signal transduction cascade. In addition, we wanted to assess the effects of chronic melatonin exposure on MT1 and MT2 melatonin receptor-mediated stimulation of PI hydrolysis. We also assessed the effects of chronic melatonin exposure on other parameters of the MT2 melatonin receptor function including total specific 2-[]-iodomelatonin binding, the affinity of melatonin for the receptor, and melatonin (1 nM)-mediated inhibition of cyclic 3′,5′-adenosine monophosphate (cAMP) accumulation. Investigation of the PI signal transduction cascade activated by either the MT1 or MT2 melatonin receptor expressed in Chinese hamster ovary (CHO) cells showed that melatonin (1 pM to 1 mM) was able to stimulate the formation of PIs to ∼40–60% over basal [ec50: MT1=29 nM (2–300 nM) and MT2=1.1 nM (0.32–3.5 nM), N=5]. This response was mediated via receptors based upon the findings that melatonin did not stimulate the formation of PIs in CHO cells devoid of receptor and that antagonism of MT2 melatonin receptors by 4P-PDOT (AH 024; 4-phenyl-2-propionamidotetralin) attenuated melatonin-mediated stimulation of PI hydrolysis in CHO cells expressing the MT2 melatonin receptor. The consequence of chronic melatonin exposure on MT1 and MT2 receptor function was also examined. Pretreatment of either MT1- or MT2-CHO cells with melatonin (1 μM for 5 hr) resulted in: (a) a complete loss of melatonin-mediated stimulation of PI hydrolysis, and (b) an attenuation of melatonin (1 nM)-mediated inhibition of forskolin-induced cAMP accumulation by ∼20–40%. The desensitization of the PI hydrolysis signal transduction cascades coupled to either MT1 or MT2 melatonin receptors following chronic melatonin exposure was not due to depleted phospholipid pools, to elevated basal levels, or to decreases in receptor affinity and density. This dual coupling of melatonin receptors to different signal transduction cascades may contribute to the diversity of melatonin receptor function in vivo.
    Biochemical Pharmacology.
  • Source
    Article: [Opioid-induced hyperalgesia. Pathophysiology and clinical relevance].
    [show abstract] [hide abstract]
    ABSTRACT: Opioids are the drugs of choice for the treatment of moderate to severe acute and chronic pain. However, clinical evidence suggests that opioids can elicit increased sensitivity to noxious stimuli suggesting that administration of opioids can activate both pain inhibitory and pain facilitatory systems. Acute receptor desensitization via uncoupling of the receptor from G-proteins, up-regulation of the cAMP pathway, activation of the N-methyl-D-aspartate (NMDA) receptor system, as well as descending facilitation, have been proposed as potential mechanisms underlying opioid-induced hyperalgesia. Numerous reports exist demonstrating that opioid-induced hyperalgesia is observed both in animal and human experimental models. Brief exposures to micro-receptor agonists induce long-lasting hyperalgesic effects for days, which might by reflected by clinical observations that large doses of intraoperative micro-receptor agonists increased postoperative pain and morphine consumption. Furthermore, the prolonged use of opioids in patients often requires increasing doses and may be accompanied by the development of abnormal pain. Successful strategies that may decrease or prevent opioid-induced hyperalgesia include the concomitant administration of drugs like NMDA-antagonists, alpha(2)-agonists, or non-steroidal anti-inflammatory drugs (NSAIDs), opioid rotation or combinations of opioids with different receptor selectivity.
    Der Anaesthesist 06/2004; 53(5):455-66. · 0.99 Impact Factor
  • Source
    Article: Dual coupling of MT(1) and MT(2) melatonin receptors to cyclic AMP and phosphoinositide signal transduction cascades and their regulation following melatonin exposure.
    [show abstract] [hide abstract]
    ABSTRACT: In this investigation, we wanted to determine whether MT(1) or MT(2) melatonin receptors are capable of coupling to the phosphoinositide (PI) signal transduction cascade. In addition, we wanted to assess the effects of chronic melatonin exposure on MT(1) and MT(2) melatonin receptor-mediated stimulation of PI hydrolysis. We also assessed the effects of chronic melatonin exposure on other parameters of the MT(2) melatonin receptor function including total specific 2-[125I]-iodomelatonin binding, the affinity of melatonin for the receptor, and melatonin (1nM)-mediated inhibition of cyclic 3',5'-adenosine monophosphate (cAMP) accumulation. Investigation of the PI signal transduction cascade activated by either the MT(1) or MT(2) melatonin receptor expressed in Chinese hamster ovary (CHO) cells showed that melatonin (1pM to 1mM) was able to stimulate the formation of PIs to approximately 40-60% over basal [EC(50): MT(1)=29nM (2-300nM) and MT(2)=1.1nM (0.32-3.5nM), N=5]. This response was mediated via receptors based upon the findings that melatonin did not stimulate the formation of PIs in CHO cells devoid of receptor and that antagonism of MT(2) melatonin receptors by 4P-PDOT (AH 024; 4-phenyl-2-propionamidotetralin) attenuated melatonin-mediated stimulation of PI hydrolysis in CHO cells expressing the MT(2) melatonin receptor. The consequence of chronic melatonin exposure on MT(1) and MT(2) receptor function was also examined. Pretreatment of either MT(1)- or MT(2)-CHO cells with melatonin (1 microM for 5hr) resulted in: (a) a complete loss of melatonin-mediated stimulation of PI hydrolysis, and (b) an attenuation of melatonin (1nM)-mediated inhibition of forskolin-induced cAMP accumulation by approximately 20-40%. The desensitization of the PI hydrolysis signal transduction cascades coupled to either MT(1) or MT(2) melatonin receptors following chronic melatonin exposure was not due to depleted phospholipid pools, to elevated basal levels, or to decreases in receptor affinity and density. This dual coupling of melatonin receptors to different signal transduction cascades may contribute to the diversity of melatonin receptor function in vivo.
    Biochemical Pharmacology 03/2002; 63(4):587-95. · 4.70 Impact Factor

Keywords

agonist-induced desensitization
 
beta-arrestin 2
 
C-terminal 26 amino acids
 
co-expressed delta opioid receptor-evoked responses
 
Co-expression
 
desensitization rate
 
G protein receptor kinases
 
G protein-activated inwardly rectifying potassium channels
 
GRK3/beta-arrestin 2-dependent desensitization
 
GRKs
 
kappa agonist-induced potassium current
 
kappa agonists
 
kappa opioid receptor
 
KOR desensitization
 
KOR desensitization rate
 
oocytes co-expressing KOR
 
rat kappa opioid receptor
 
rKOR
 
truncation
 
Xenopus oocyte expression system
 

Victor Pineda